Ian Simon | When following the science isn’t enough: risk, communication, and the future of biotechnology | TPM podcast #52

Ian Simon | When following the science isn’t enough: risk, communication, and the future of biotechnology | TPM podcast #52

From Talking Precision Medicine by Genialis

December 12, 2025 · 40 min · Season 8 · Episode 11

About this episode

Ian Simon discusses the intersection of biotechnology, public health, and the impact of AI on science.

In this episode, I’m joined by my longtime friend Ian Simon , Head of Biotechnology at Aspis Intelligence. Ian’s path runs from grad school vaccine research at Yale to senior roles at the White House, HHS, NIH, the State Department, and the Office of Long Covid. We talk about de-risking young biotech companies, what Covid taught us about science and public health, and how new technologies like AI might change how we do science altogether. ⁠⁠⁠TPM E52 highlights >⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Episode 52 links: Ian Simon on LinkedIn Aspis Intelligence

People in this episode

Guest: Ian Simon

Topics covered

  • biotechnology
  • public health
  • AI in science
  • Covid-19
  • risk communication
  • de-risking biotech

Keywords

  • biotechnology
  • public health
  • AI
  • Covid-19
  • risk communication
  • de-risking
  • vaccine research

Mentioned in this episode

Organizations: Aspis Intelligence, Yale, White House, HHS, NIH, State Department, Office of Long Covid

More episodes of Talking Precision Medicine

Explore listener stats, chart rankings, contacts and more on the Talking Precision Medicine podcast page.